Aura Biosciences, Inc. (AURA)
NASDAQ · Manufacturing · Biological products, (no diagnostic substances)
$6.00−$0.1500 (−2.44%) on the dayAs of the close; data may be delayed.
AURA price, last 12 months
Key stats
- Previous close
- $6.15
- Open
- $6.18
- Day range
- $5.99 – $6.18
- 52-week range
- $4.73 – $9.54
- Volume
- 1.1M
- Avg volume (20 days)
- 885K
- Market cap
- $622.2M
Performance
1W−6.8%
1M−22.4%
3M−14.3%
6M−6.8%
YTD+10.1%
1Y−2.8%
vs S&P 500, 1Y−19.5 pts
Technicals and fundamentals
About Aura Biosciences, Inc.
Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.
- Sector
- Manufacturing
- Industry
- Biological products, (no diagnostic substances)
- Listed on
- NASDAQ
- Market cap
- $622.2M